ArticleACS medicinal chemistry letters2010

Docking Small Molecules to Predicted Off-Targets of the Cancer Drug Erlotinib Leads to Inhibitors of Lung Cancer Cell Proliferation with Suitable In vitro Pharmacokinetic Properties.

Liwei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.